The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US.
It is a question I ask myself everyday… but I have no clear answer. From a day-to-day perspective, I am not seeing the pressure reducing,” said Abhay Gandhi the CEO of Sun Pharma’s North America business, in a rather pensive mood at the company’s third-quarter earnings call. Sun Pharma, India’s largest pharmaceutical firm has been fighting tooth and nail to hold its ground in an extremely competitive pricing environment in its biggest market, the US. Companies across the pharma industry, both main players as well as channel partners, are consolidating even as prices of drugs are falling like there’s no tomorrow. The carnage seems never-ending — at least for a few years.
And there are two solid reasons why the pricing pressure on the generic business will continue. First, there is rapid consolidation among customers of generic drug makers, which drastically reduces their bargaining power and second, the intense competition among generic drug-makers. “Earlier a pharmacy was acquiring another pharmacy; an insurance company was acquiring another insurance company. Now, the retail firm is acquiring the insurance firm and vice versa. While there was vertical consolidation earlier, now it’s horizontal, but consolidation itself is relentless. So, negotiating power of the generic companies is reducing vis-a-vis the big customers, who are buying the medicines from them,” explains Deepak Malik, pharma analyst at Edelweiss Securities.
This story is from the May 11, 2018 edition of Outlook Business.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 11, 2018 edition of Outlook Business.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
THE JOY OF ADJUSTING A LITTLE
Partha DeSarkar, executive director and CEO of Hinduja Global Solutions, not only advocates making small adjustments but also taking oneself less seriously to remain happy
MONEY PLANT
Firms are popping up to help people and companies plant saplings. Reasons for this green consciousness range from earning carbon credits to a desire to fight deforestation
AI'S NEW PORN POSITION
Deepfakes and artificial intelligence-generated images have breathed new life into the porn industry. Celebrities have become the latest victims and revenge porn is on the rise
HOUSE OF CARDS
At 8.4%, India’s GDP surpassed the expectations of analysts of almost all dispositions. But are GDP numbers hiding a bleaker story? It is not just the missing private money, there are more devils in the story
'Markets Can See More Price Correction in the Coming Quarters'
Sunil Koul, executive director Asia Pacific portfolio strategy, global macro research) at Goldman Sachs, in an exclusive interview with Ayaan Kartik and Neeraj Thakur, talks about the valuation situation in India and how foreign investors are looking at increasing their bets in the equity markets
MARKETS, RETAIL INVESTORS TANGO TO NEW HIGHS
As more investors enter the markets, the palette of investing style becomes more colourful. Each investor brings in their own biases, impulsive actions and assumptions to the markets.
GREED OVER FUNDAMENTALS: THE INVESTOR'S FOLLY
In her address at the fifth SEBI-NISM research conference on March 12, 2024, Securities and Exchange Board of India (SEBI) chief Madhabi Puri Buch expressed her concerns about the valuation froth in the mid- and small-cap space.
WINNING THE GAME OF BULLS AND BEARS
While retail investors rushed to make hay as smalland mid-cap stocks shone at the bourses, institutional investors stayed away, guided by traditional wisdom that warned them against the exuberance in the stock market. The mid-March crash, dominated by the smaller segments, proved their point
DELIRIUM IN THE MARKETS
Market regulator SEBI says there is froth” in the mid-and small-cap stocks; banker Uday Kotak says there is no bubble. Caught in this cross-current are traders in small towns who are betting heavily in risky derivatives. What is next for the turbocharged Indian markets and what of the retail investors rallying behind it?
Dynamic Women Achievers
Discover the vibrant narratives of dynamic women achievers breaking barriers and reshaping the landscape across diverse fields. From trailblazing entrepreneurs to influential thought leaders, this article celebrates the resilience, innovation, and impactful contributions of women who defy norms, inspiring a new era of empowerment and progress.